The Food and Drug Administration will start actively regulating tests developed in laboratories, with some exemptions, the agency announced on Monday. The agency’s action, which is expected to face legal challenges in courts, comes after Congress failed to pass a law to regulate such tests.
The tests have not faced FDA scrutiny historically, as the agency considered them low-risk. But the tests have grown in power and complexity since the FDA first started regulating medical devices in 1976. The infamous faulty blood tests from Theranos fall into this category, as well as misleading prenatal genetic tests.
“The agency cannot stand by while Americans continue to rely on results from these tests without assurance that they work,” FDA Commissioner Robert Califf said on a media call.
Click this link for the original source of this article.
Author: Lizzy Lawrence
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.